According to studies reviewed in the presented manuscript, the most promising ADPKD prognostic biomarkers are molecules involved in the disease pathogenesis: markers of tubular injury, inflammation, metabolism, the renin-angiotensin or the vasopressin system. This evidence concerns the gene REN and autosomal dominant polycystic kidney disease.